Octopus Biosafety SA (EPA:MLOCT)
France · Delayed Price · Currency is EUR 0.2700
+0.0200 (8.00%)
Oct 7, 2025, 4:32 PM CET
Octopus Biosafety Revenue
In the year 2024, Octopus Biosafety had annual revenue of 385.11K EUR, down -41.27%.
Revenue
385.11K
Revenue Growth
-41.27%
P/S Ratio
89.13
Revenue / Employee
64.19K
Employees
6
Market Cap
34.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 385.11K | -270.58K | -41.27% |
| Dec 31, 2023 | 655.69K | 378.21K | 136.30% |
| Dec 31, 2022 | 277.48K | -259.45K | -48.32% |
| Dec 31, 2021 | 536.93K | -124.74K | -18.85% |
| Dec 31, 2020 | 661.67K | 648.73K | 5,013.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dassault Systèmes SE | 6.31B |
| STMicroelectronics | 10.12B |
| Capgemini SE | 22.07B |
| Rexel | 19.43B |
| Tatatu | 84.19M |
| VusionGroup | 1.16B |
| Sopra Steria Group | 5.67B |
| Alten | 4.12B |